Back to MW MARSHALL WACE, LLP

MAZEMAZE
6 quarters

Position history for MWMARSHALL WACE, LLP's holdings in MAZE THERAPEUTICS INC

MARSHALL WACE, LLP holds 914,572 shares of MAZE (MAZE THERAPEUTICS INC), worth $27.3M as of 2026-Q2. The position was increased (+194.4% shares). MAZE represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$27.3M

Current Shares

914,572

Total Value Change

+$27.1M

Total Shares Change

+894,975

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
914,572
+194.4%
$27.3M0.0%$29.84
46
2026-Q1
Decreased
310,639
-63.4%
$9.3M0.0%$44.18
0
2025-Q4
Increased
847,472
+9.0%
$35.1M0.0%$40.05
32
2025-Q3
Increased
777,701
+3868.5%
$20.2M0.0%$25.20
46
2025-Q2
Unchanged
19,597
0.0%
$240,4550.0%$12.13
0
2025-Q1
New
19,597
-
$215,7630.0%$11.42
32

Other major holders of MAZE: Janus Henderson Group Ltd., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used